Adherence to Nutritional Treatment Following MI Using Telemedicine Treatment (ADNUT)
Conditions: Cardiovascular Diseases; Acute MI Intervention: Behavioral: Medical Nutrition Therapy (counselling) Sponsors: Ariel University; Prof. Robert Klempfner, The Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Prof. Yaacov Henkin, Soroka University Medical Center, Beer Sheva, Israel; Dana Dishon, RD, MSc, The Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Dana Weiner, R D, MS, The Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
Adherence to Nutritional Treatment Following MI Using Telemedicine Treatment (ADNUT)
Conditions: Cardiovascular Diseases; Acute MI Intervention: Behavioral: Medical Nutrition Therapy (counselling) Sponsors: Ariel University; Prof. Robert Klempfner, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Prof. Yaacov Henkin, Soroka University Medical Center, Beer Sheva, Israel; Dana Dishon, RD, MSc, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Dana Weiner, RD, MS, C haim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
Todos Medical Completes Trial Design for Tollovid Long COVID Clinical Study in Adults
New York, NY, and Tel Aviv, ISRAEL, Aug. 11, 2022. Tdos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd has finalized plans for a proposed safety... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 11, 2022 Category: Pharmaceuticals Source Type: clinical trials
Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation
Condition: Arteriovenous Malformations Interventions: Drug: MedroxyPROGESTERone Injection [Depo-Provera]; Device: Other Sponsor: HaEmek Medical Center, Israel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2022 Category: Research Source Type: clinical trials
